美股市場個股詳情
WCGC WCG Clinical
- 0.000
- 0.0000.00%
收盤價 05/17 09:30 (美東)
0總市值0.00市盈率TTM
0.000最高價0.000最低價0股成交量0.000今開0.000昨收0.00成交額0.00%換手率0.00市盈率(靜)3.79億總股本0.00052周最高0.00市淨率0流通值0.00052周最低--股息TTM4500.00萬流通股0.000歷史最高--股息率TTM0.00%振幅0.000歷史最低--平均價1股每手
關於WCG Clinical公司
WCG 臨床公司是臨床試驗解決方案的提供商。其轉型解決方案使生物製藥公司、CROS 和機構能夠加速為患者提供新的治療和治療，同時保持最高標準的人類保護。
公司介紹
公司代碼WCGC
公司名稱WCG Clinical
CEOMr. Donald A. Deieso
所屬市場納斯達克
員工數量4400
證券類型海外普通股
董事高管
- 姓名
- 職務
- 年薪
- Donald A. Deieso
- Executive Chairman of the Board and Chief Executive Officer
- --
- Barbara J. Shander
- Chief Legal Officer and Executive Vice President, Corporate Development
- --
- Nicholas Slack
- President and Chief Commercial Officer
- --
- Laurie L. Jackson
- Chief Financial Officer, Principal Accounting Officer and Chief Administration Officer
- --
- Dawn Flitcraft
- President, Ethical Review Division
- --
- Stephen M. McLean
- Independent Director
- --
- Peter Zippelius
- Independent Director
- --
- Dr. Kavita K. Patel, M.D.
- Independent Director
- --
- Dr. Charles D. Kennedy, M.D.
- Independent Director
- --
- Richard D. Pilnik
- Lead Independent Director
- --
- Eugene Gorbach
- Independent Director
- --
- John M. Baumer
- Independent Director
- --
- Henrik Kjaer Hansen
- Independent Director
- --
- Dr. James E. Rothman,PhD
- Independent Director
- --
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅